318 related articles for article (PubMed ID: 12397090)
1. Protein kinase C inhibits amyloid beta peptide neurotoxicity by acting on members of the Wnt pathway.
Garrido JL; Godoy JA; Alvarez A; Bronfman M; Inestrosa NC
FASEB J; 2002 Dec; 16(14):1982-4. PubMed ID: 12397090
[TBL] [Abstract][Full Text] [Related]
2. M1 muscarinic receptor activation protects neurons from beta-amyloid toxicity. A role for Wnt signaling pathway.
Farías GG; Godoy JA; Hernández F; Avila J; Fisher A; Inestrosa NC
Neurobiol Dis; 2004 Nov; 17(2):337-48. PubMed ID: 15474371
[TBL] [Abstract][Full Text] [Related]
3. Amyloid-beta-induced neurotoxicity is reduced by inhibition of glycogen synthase kinase-3.
Koh SH; Noh MY; Kim SH
Brain Res; 2008 Jan; 1188():254-62. PubMed ID: 18031715
[TBL] [Abstract][Full Text] [Related]
4. Wnt-3a overcomes beta-amyloid toxicity in rat hippocampal neurons.
Alvarez AR; Godoy JA; Mullendorff K; Olivares GH; Bronfman M; Inestrosa NC
Exp Cell Res; 2004 Jul; 297(1):186-96. PubMed ID: 15194435
[TBL] [Abstract][Full Text] [Related]
5. Tcf-1-mediated transcription in T lymphocytes: differential role for glycogen synthase kinase-3 in fibroblasts and T cells.
Staal FJ; Burgering BM; van de Wetering M; Clevers HC
Int Immunol; 1999 Mar; 11(3):317-23. PubMed ID: 10221643
[TBL] [Abstract][Full Text] [Related]
6. The anti-inflammatory and cholinesterase inhibitor bifunctional compound IBU-PO protects from beta-amyloid neurotoxicity by acting on Wnt signaling components.
Farías GG; Godoy JA; Vázquez MC; Adani R; Meshulam H; Avila J; Amitai G; Inestrosa NC
Neurobiol Dis; 2005 Feb; 18(1):176-83. PubMed ID: 15649708
[TBL] [Abstract][Full Text] [Related]
7. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.
Chen RH; Ding WV; McCormick F
J Biol Chem; 2000 Jun; 275(23):17894-9. PubMed ID: 10749878
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E and beta-amyloid (1-42) regulation of glycogen synthase kinase-3beta.
Cedazo-Mínguez A; Popescu BO; Blanco-Millán JM; Akterin S; Pei JJ; Winblad B; Cowburn RF
J Neurochem; 2003 Dec; 87(5):1152-64. PubMed ID: 14622095
[TBL] [Abstract][Full Text] [Related]
10. Developmental expression of Wnt signaling factors in mouse brain.
Coyle-Rink J; Del Valle L; Sweet T; Khalili K; Amini S
Cancer Biol Ther; 2002; 1(6):640-5. PubMed ID: 12642687
[TBL] [Abstract][Full Text] [Related]
11. Regulation of lymphoid enhancer factor 1/T-cell factor by mitogen-activated protein kinase-related Nemo-like kinase-dependent phosphorylation in Wnt/beta-catenin signaling.
Ishitani T; Ninomiya-Tsuji J; Matsumoto K
Mol Cell Biol; 2003 Feb; 23(4):1379-89. PubMed ID: 12556497
[TBL] [Abstract][Full Text] [Related]
12. The human Frizzled 6 (HFz6) acts as a negative regulator of the canonical Wnt. beta-catenin signaling cascade.
Golan T; Yaniv A; Bafico A; Liu G; Gazit A
J Biol Chem; 2004 Apr; 279(15):14879-88. PubMed ID: 14747478
[TBL] [Abstract][Full Text] [Related]
13. [Involvement of Wnt/beta-catenin signaling in tripchlorolide protecting against oligomeric beta-amyloid-(1-42)-induced neuronal apoptosis].
Wu M; Zhu YG; Pan XD; Lin N; Zhang J; Chen XC
Yao Xue Xue Bao; 2010 Jul; 45(7):853-9. PubMed ID: 20931782
[TBL] [Abstract][Full Text] [Related]
14. Suppression of glycogen synthase kinase activity is not sufficient for leukemia enhancer factor-1 activation.
Yuan H; Mao J; Li L; Wu D
J Biol Chem; 1999 Oct; 274(43):30419-23. PubMed ID: 10521419
[TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrils.
De Ferrari GV; Chacón MA; Barría MI; Garrido JL; Godoy JA; Olivares G; Reyes AE; Alvarez A; Bronfman M; Inestrosa NC
Mol Psychiatry; 2003 Feb; 8(2):195-208. PubMed ID: 12610652
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the versican promoter by the beta-catenin-T-cell factor complex in vascular smooth muscle cells.
Rahmani M; Read JT; Carthy JM; McDonald PC; Wong BW; Esfandiarei M; Si X; Luo Z; Luo H; Rennie PS; McManus BM
J Biol Chem; 2005 Apr; 280(13):13019-28. PubMed ID: 15668231
[TBL] [Abstract][Full Text] [Related]
17. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
Hämmerlein A; Weiske J; Huber O
Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of Puerarin on β-amyloid-induced neurotoxicity in rat hippocampal neurons.
Lin F; Xie B; Cai F; Wu G
Arzneimittelforschung; 2012 Apr; 62(4):187-93. PubMed ID: 22278629
[TBL] [Abstract][Full Text] [Related]
19. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
Sakanaka C; Weiss JB; Williams LT
Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
[TBL] [Abstract][Full Text] [Related]
20. Negative regulation of the Wnt-beta-catenin pathway by the transcriptional repressor HBP1.
Sampson EM; Haque ZK; Ku MC; Tevosian SG; Albanese C; Pestell RG; Paulson KE; Yee AS
EMBO J; 2001 Aug; 20(16):4500-11. PubMed ID: 11500377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
